4-Dimethylaminophenylarsine Drug Intermediate from Canada
This aromatic organo-arsenic compound serves as a key intermediate in synthesizing anti-parasitic drugs. Classified under HTS 2931.90.22.00 due to its aromatic structure with arsenic directly bonded to carbon and designated pharmaceutical application.
Duty Rate — Canada → United States
16.5%
Rate breakdown
9903.05.2910%Section 301 (forced labor) — additional 10% ad valorem on products of Canada
Import Tips
• Submit synthesis pathway documentation proving direct C-As bond to avoid reclassification as sulfonated derivative
• Include end-use statement from pharmaceutical manufacturer to maintain 'drugs' designation
• Monitor REACH/TSCA registration for arsenic compounds to ensure environmental compliance